No tiene artículos en su carrito de compras.
Psilocybin Science & News
Stay up to date with psilocybin research and psychedelic science. Here you’ll find easy-to-read explainers, study breakdowns, and news on therapy, safety, and new discoveries around magic mushrooms.
-
Scientists have just described a new magic mushroom species — and it turns out millions of growers have been cultivating it for years without knowing. The new magic mushroom species is called Psilocybe ochraceocentrata, and it was hiding in plain sight behind the popular names "Natal Super Strength" (NSS) and "Transkei." In other words, these were never strains of Psilocybe cubensis at all. And here at Magic Mushrooms Shop, we already carry the world's first hybrid made from this new magic mushroom species: the Yellow Umbo.
Psilocybin legalisation is no longer a distant dream — it is happening right now. In the first months of 2026, three major developments in the United States have shifted the legal landscape for magic mushrooms faster than ever before. A pharmaceutical company is preparing to file the first-ever psilocybin drug application with the FDA. The DEA has dramatically increased how much psilocybin can be legally produced. And more than a dozen U.S. states are actively writing psilocybin into law. Together, these events signal a turning point — not just for the U.S., but for the world.
Can psilocybin treat OCD? A groundbreaking Yale University study says yes — and the results are remarkable. In this first-ever randomized, placebo-controlled trial, just one dose of psilocybin — the psychoactive compound in magic mushrooms — reduced obsessive-compulsive disorder symptoms within 48 hours. Even more striking, the benefits lasted for months. For the millions of people living with treatment-resistant OCD, this psilocybin OCD research opens an entirely new door.
Ketamine Assisted Therapy 101
February 12, 2024
Ketamine started as a surgical anesthetic. Today, it is one of the most promising tools in mental health treatment. If you struggle with treatment-resistant depression, PTSD, or chronic anxiety, ketamine-assisted therapy may offer the rapid relief you have been looking for.
In this guide, you will learn what ketamine is, how therapy sessions work, and what you need to know before you begin.
A clear guide to synthetic psychedelics — LSD, MDMA, 2C-B, ketamine, research chemicals, and the critical difference between tested and untested substances. (2026 Update)
How MDMA, psilocybin, and other psychedelics are being studied as tools for healing trauma — including the Gabor Maté perspective. (2026 Update)
Why magic mushroom spores don't contain psilocybin ?
March 10, 2023
Spores are a type of reproductive cell produced by fungi that are essential to their life cycle. In the case of magic mushrooms, spores are used to create new mycelial networks and ultimately, new fruiting bodies. However, one interesting fact about magic mushroom spores is that they do not contain psilocybin, the active compound responsible for the mushrooms' psychoactive effects.
Continue readingMyths & Misconceptions About Psychedelics: The Truth Behind 8 Common Claims
September 26, 2022
Debunking the Most Common Myths and Misconceptions About Psychedelics (2026 Update)
Psychedelics have been surrounded by fear, rumour, and misinformation for decades. Much of what most people "know" about them was shaped not by science, but by political campaigns from the 1970s — campaigns designed to discourage use rather than inform. Today, with research from universities like Johns Hopkins and Imperial College London producing serious data, we have the tools to look at these myths more honestly.
How psilocybin, MDMA, and other psychedelics are reshaping psychedelics mental health treatment — a comprehensive 2026 guide.
Psilocybin and religious leaders — from a 2017 news story to landmark published results in 2025. Here is everything we know about this groundbreaking study.
In this guide: In 2015, researchers at Johns Hopkins University and NYU launched a landmark clinical trial. They gave psilocybin — the active compound in magic mushrooms — to two dozen religious leaders from four major world religions. The results, finally published in 2025, reveal that 96% of participants rated the experience among the top five most spiritually significant moments of their lives.
This post covers the full story: the study design, the key findings, the controversy that delayed publication, and what it all means for the future of psilocybin research.
